Search companies or stocks...
BCABBioAtla, Inc.
At close · 28 Aug 2026, 08:00 pm
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead…
Current stock price of BioAtla, Inc. (BCAB) stock is $1.740. The stock price is +0.00% higher in the session. The intraday range can be seen from this page. Volume of BioAtla, Inc. (BCAB) stock is 1.03M.
Last updated at 28 Aug 2026, 08:00 pm.
The stock price of BioAtla, Inc. (BCAB) can change with earnings, company news, and overall market sentiment. BioAtla, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.
Whether BioAtla, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for BCAB on this page is -0.12. EPS on this page is -14.76. Compare those figures with peers and growth expectations before deciding if the current BioAtla, Inc. price is justified.
Historical performance for BioAtla, Inc. (BCAB) is shown on the price chart on this page. Review multi-period moves alongside volume to see how BCAB reacted to past earnings and market events.
Buying BioAtla, Inc. (BCAB) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.
